Infinity Pharmaceuticals, Inc. (INFIQ)
Develops cancer drugs targeting immune system enzymes to fight solid tumors.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+900.0%
The outlook
INFIQ trades at its 52-week high after moving above both its 50- and 200-day moving averages, suggesting upward momentum in its recent trend. Analyst coverage appears minimal for this micro-cap stock. The current price sits at the upper end of its yearly trading range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$9,076
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—